Related Experiment Videos
The problem of gastric atony
1Department of Emergency and Critical Care, The Bobst Hospital of The Animal Medical Center, New York, NY 10021, USA. kristen.woosley@amcny.edu
Clinical Techniques in Small Animal Practice
|March 18, 2004
Summary
Critically ill animals often develop gastroparesis, leading to complications. Promotility drugs offer a safe and effective solution for improving gastrointestinal function and patient recovery in intensive care settings.
Area of Science:
- Veterinary Medicine
- Gastroenterology
- Critical Care
Background:
- Normal gastrointestinal motility is essential for gut microbiota balance.
- Impaired motility can lead to bacterial overgrowth, translocation, pneumonia, and sepsis.
- Critically ill animals are prone to gastroparesis due to primary GI issues or metabolic dysfunction.
Purpose of the Study:
- To highlight the risks associated with delayed gastric emptying in critically ill animals.
- To emphasize the benefits of promotility drugs in managing gastroparesis.
- To guide clinicians in selecting appropriate prokinetic therapies.
Main Methods:
- Review of the pathophysiology of gastroparesis in critically ill animals.
- Discussion of the impact of delayed gastric emptying on nutritional support and patient outcomes.
- Analysis of available promotility drugs and their mechanisms of action.
Main Results:
- Delayed gastric emptying in critically ill patients complicates enteral nutrition.
- Severe illness exacerbates caloric depletion, impairing healing and immune function.
- Promotility drugs are safe and effective for treating gastric atony and enhancing recovery.
Conclusions:
- Promotility drug use is a vital strategy for critically ill animals with gastroparesis.
- Understanding drug interactions with gastrointestinal neuromuscular transmission is key for optimal therapy selection.
- Effective management of gastroparesis improves patient outcomes and reduces morbidity/mortality.